BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 29947931)

  • 1. Imaging and the completion of the omics paradigm in breast cancer.
    Leithner D; Horvat JV; Ochoa-Albiztegui RE; Thakur S; Wengert G; Morris EA; Helbich TH; Pinker K
    Radiologe; 2018 Nov; 58(Suppl 1):7-13. PubMed ID: 29947931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multimodal, multiparametric and genetic breast imaging].
    LoGullo R; Horvat J; Reiner J; Pinker K
    Radiologe; 2021 Feb; 61(2):183-191. PubMed ID: 33464404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Background, current role, and potential applications of radiogenomics.
    Pinker K; Shitano F; Sala E; Do RK; Young RJ; Wibmer AG; Hricak H; Sutton EJ; Morris EA
    J Magn Reson Imaging; 2018 Mar; 47(3):604-620. PubMed ID: 29095543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omics-based biomarkers: current status and potential use in the clinic.
    Quezada H; Guzmán-Ortiz AL; Díaz-Sánchez H; Valle-Rios R; Aguirre-Hernández J
    Bol Med Hosp Infant Mex; 2017; 74(3):219-226. PubMed ID: 29382490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer.
    Bellini D; Milan M; Bordin A; Rizzi R; Rengo M; Vicini S; Onori A; Carbone I; De Falco E
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Omics Data Can Be Used in Nephrology.
    Rhee EP
    Am J Kidney Dis; 2018 Jul; 72(1):129-135. PubMed ID: 29478865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment.
    Pinker K; Chin J; Melsaether AN; Morris EA; Moy L
    Radiology; 2018 Jun; 287(3):732-747. PubMed ID: 29782246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast MRI radiogenomics: Current status and research implications.
    Grimm LJ
    J Magn Reson Imaging; 2016 Jun; 43(6):1269-78. PubMed ID: 26663695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions.
    Gallivanone F; Bertoli G; Porro D
    Methods Protoc; 2022 Oct; 5(5):. PubMed ID: 36287050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiogenomics: bridging imaging and genomics.
    Bodalal Z; Trebeschi S; Nguyen-Kim TDL; Schats W; Beets-Tan R
    Abdom Radiol (NY); 2019 Jun; 44(6):1960-1984. PubMed ID: 31049614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data analysis methods for defining biomarkers from omics data.
    Li C; Gao Z; Su B; Xu G; Lin X
    Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiomics technologies: role in disease biomarker discoveries and therapeutics.
    Dar MA; Arafah A; Bhat KA; Khan A; Khan MS; Ali A; Ahmad SM; Rashid SM; Rehman MU
    Brief Funct Genomics; 2023 Apr; 22(2):76-96. PubMed ID: 35809340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Omics Analyses Enabled by Microchip Technologies.
    Deng Y; Finck A; Fan R
    Annu Rev Biomed Eng; 2019 Jun; 21():365-393. PubMed ID: 30883211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments.
    Gómez-Cebrián N; Domingo-Ortí I; Poveda JL; Vicent MJ; Puchades-Carrasco L; Pineda-Lucena A
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572770
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.